EUVIMEDEUVIMED entdecken
Crossref

Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease

Lucas C Godoy, Michael E Farkouh, Peter C Austin, Baiju R Shah, Feng Qiu, Cynthia A Jackevicius, Harindra C Wijeysundera, Harlan M Krumholz, Dennis T Ko

Journal of the American College of Cardiology · 2023-06 · 81 (24) · 2299-2311

DOI: 10.1016/j.jacc.2023.04.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American College of Cardiology, 2023-06. Verfasst von Lucas C Godoy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Peter Munk Cardiac Centre and Heart and Stroke Richard Lewar Centre, University of Toronto, Toronto, Ontario, Canada; ICES, Toronto, Ontario, Canada;…. Hauptthemen laut MEDLINE: Cardiovascular System, Myocardial Ischemia, Coronary Artery Disease, Heart Failure. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Previous studies have failed to show a cardioprotective benefit of beta-blockers in patients with stable coronary artery disease (CAD). OBJECTIVES: This study sought to determine the association between beta-blockers and cardiovascular events in patients with stable CAD using a new user design. METHODS: All patients aged >66 years undergoing elective coronary angiography in Ontario, Canada, from 2009 to 2019 with diagnosed obstructive CAD were included. Exclusion criteria included heart failure or a recent myocardial infarction, as well as having a beta-blocker prescription claim in the previous year. Beta-blocker use was defined as having at least 1 beta-blocker prescription claim in the 90 days preceding or after the index coronary angiography. The main outcome was a composite of all-cause mortality and hospitalization for heart failure or myocardial infarction. Inverse probability of treatment weighting using the propensity score was used to account for confounding. RESULTS: This study included 28,039 patients (mean age: 73.0 ± 5.6 years; 66.2% male), and 12,695 of those (45.3%) were newly prescribed beta-blockers. The 5-year risks of the primary outcome were 14.3% in the beta-blocker group and 16.1% in the no beta-blocker group (absolute risk reduction: -1.8%; 95% CI: -2.8 to -0.8; HR: 0.92; 95% CI: 0.86-0.98; P = 0.006). This result was driven by reductions in myocardial infarction hospitalization (cause-specific HR: 0.87; 95% CI: 0.77-0.99; P = 0.031), whereas no differences were observed in all-cause death or heart failure hospitalization. CONCLUSIONS: In patients with angiographically documented stable CAD without heart failure or a recent myocardial infarction, beta-blockers were associated with a small but significant reduction in cardiovascular events at 5 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular SystemMyocardial IschemiaCoronary Artery DiseaseHeart FailureMyocardial InfarctionHumansMaleAgedFemaleOntario

Stichwörter der Autor:innen

beta-blockercardiovascular outcomesstable coronary artery disease

Autor:innen und Institutionen

  • Peter Munk Cardiac Centre and Heart and Stroke Richard Lewar Centre, University of Toronto, Toronto, Ontario, Canada; ICES, Toronto, Ontario, Canada; Institute of Health Policy Management, and Evaluation, University of…
  • Peter Munk Cardiac Centre and Heart and Stroke Richard Lewar Centre, University of Toronto, Toronto, Ontario, Canada; Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • ICES, Toronto, Ontario, Canada; Institute of Health Policy Management, and Evaluation, University of Toronto, Ontario, Canada.
  • ICES, Toronto, Ontario, Canada; Institute of Health Policy Management, and Evaluation, University of Toronto, Ontario, Canada; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • ICES, Toronto, Ontario, Canada.
  • ICES, Toronto, Ontario, Canada; Institute of Health Policy Management, and Evaluation, University of Toronto, Ontario, Canada; Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, USA; Wester…

Förderung

  • CIHR

Zitieren

APA

Godoy, L. C., Farkouh, M. E., Austin, P. C., Shah, B. R., Qiu, F., Jackevicius, C. A., Wijeysundera, H. C., Krumholz, H. M., & Ko, D. T. (2023). Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease. Journal of the American College of Cardiology, 81(24), 2299-2311. https://doi.org/10.1016/j.jacc.2023.04.021

Vancouver

Godoy LC, Farkouh ME, Austin PC, Shah BR, Qiu F, Jackevicius CA, et al. Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease. Journal of the American College of Cardiology. 2023;81(24):2299-2311. doi:10.1016/j.jacc.2023.04.021

BibTeX
@article{Godoy2023,
  author = {Godoy, Lucas C and Farkouh, Michael E and Austin, Peter C and Shah, Baiju R and Qiu, Feng and Jackevicius, Cynthia A and Wijeysundera, Harindra C and Krumholz, Harlan M and Ko, Dennis T},
  title = {Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease},
  journal = {Journal of the American College of Cardiology},
  year = {2023},
  volume = {81},
  number = {24},
  pages = {2299--2311},
  doi = {10.1016/j.jacc.2023.04.021}
}
Kostenlos starten →